Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Operating Expenses (2023 - 2025)

Rallybio (RLYB) has disclosed Operating Expenses for 3 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 43.04% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.9 million through Dec 2025, down 44.51% year-over-year, with the annual reading at $33.9 million for FY2025, 44.51% down from the prior year.
  • Operating Expenses hit $6.6 million in Q4 2025 for Rallybio, down from $7.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $21.1 million in Q4 2023 to a low of $6.6 million in Q4 2025.
  • Historically, Operating Expenses has averaged $14.5 million across 3 years, with a median of $14.8 million in 2024.
  • Biggest five-year swings in Operating Expenses: rose 7.69% in 2024 and later plummeted 50.06% in 2025.
  • Year by year, Operating Expenses stood at $21.1 million in 2023, then plummeted by 44.84% to $11.6 million in 2024, then plummeted by 43.04% to $6.6 million in 2025.
  • Business Quant data shows Operating Expenses for RLYB at $6.6 million in Q4 2025, $7.1 million in Q3 2025, and $10.3 million in Q2 2025.